PCN97 ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CETUXIMAB TREATMENT DECISION MODEL- CHEMOTHERAPYCETUXIMAB VS. CETUXIMAB TREAT-TO-RASH STRATEGY VS. CHEMOTHERAPY ONLY IN FIRST-LINE TREATMENT OF STAGE IIIB/IV NSCLC
May 1, 2010, 00:00
10.1016/S1098-3015(10)72186-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72186-0/fulltext
Title :
PCN97 ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CETUXIMAB TREATMENT DECISION MODEL- CHEMOTHERAPYCETUXIMAB VS. CETUXIMAB TREAT-TO-RASH STRATEGY VS. CHEMOTHERAPY ONLY IN FIRST-LINE TREATMENT OF STAGE IIIB/IV NSCLC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72186-0&doi=10.1016/S1098-3015(10)72186-0
First page :
Section Title :
Open access? :
No
Section Order :
775